The highest average peak force (N) applied resulting in disruption of mesh was polypropylene (58.99 +/-4.03) followed by V-loc (58.17 +/-6.78), 2-0 Quill (57.72 +/-5.80), , polydioxanone (44.37 +/-11.14), and 3-0 Quill (31.08 +/-13.38). In all non-Quill trials, the mesh either tore near the anchoring clamp of the pulley system or tore at sites of fascia while suture remained intact at the moment of peak tension. When Quill suture was used, the suture broke or dislodged at peak tension resulting in complete release of the intact mesh. CONCLUSION: Quill barbed suture, regardless of the size, released from fascia resulting in complete dislodgment of intact mesh at the moment of peak applied tension. In all other sutures, portions of the mesh tore before sutures broke. Importantly, while portions of mesh tore in these situations, the remaining mesh maintained its attachment to fascia. For some surgeons who use barbed sutures in place of traditional interrupted sutures to decrease operative time, consideration should be given to V-loc unidirectional barbed suture over Quill bidirectional suture for the use in vaginal mesh attachment for sacrocolpopexy.
OBJECTIVES:
Operations and Pelvic Muscle Training in the Management of Apical Support Loss (OPTIMAL) trial participants with Stage II-IV pelvic organ prolapse (POP) and stress urinary incontinence were randomized to uterosacral ligament suspension (ULS) or sacrospinous ligament fixation (SSLF). In this study, 5 year outcomes were assessed. MATERIALS AND METHODS: Ninety-two percent (285/309) of eligible 2-year OPTIMAL trial completers consented to participate in the extended-OPTIMAL study; 273 (96%), 251 (88%), 244 (86%) had assessments at 3, 4, and 5-years, respectively, between 2008 and 2013 at nine US medical centers. The surgical intervention was transvaginal surgery including midurethral sling with randomization to ULS (n ¼ 147) or SSLF (n ¼ 138); the behavioral intervention was randomization to perioperative behavioral therapy with pelvic floor muscle training (PBMT) (n ¼ 141) or usual care (n ¼ 144). The primary surgical outcome was defined as time to anatomic or symptomatic failure or retreatment. Consistent with the primary OPTIMAL study, anatomic failure was defined as apical descent greater than one-third of vaginal length (POPQ C > -2/3TVL) or anterior or posterior vaginal wall beyond the hymen (POPQ Ba or Bp > 0) and symptomatic failure was defined as bothersome vaginal bulge symptoms. The primary outcome for the behavioral intervention was anatomic failure as defined for the surgical intervention and development of POP symptoms measured by the POPDI subscale of the PFDI. RESULTS: By year 5, the estimated probabilities of success from parametric survival modeling ( Figure) for the ULS group and the SSLF group, respectively, were 0.44 and 0.33 for the primary outcome (difference of 0.10; 95% CI ¼ -0.06, 0.27), 0.57 and 0.42 for anatomic POP (difference of 0.16; 95% CI ¼ -0.04, 0.35) and 0.64 and 0.62 for symptomatic POP (difference of 0.02; 95% CI ¼ -0.14, 0.18). POP retreatment at 5 years was 12% and 8% (OR ¼ 1.6; 95% CI ¼ 0.6e4.1) including pessary (4.2%) and repeat surgery (5.3%). The 117 anatomic failures involved the apex only (29%), anterior or posterior compartment only (36%), or both apex and anterior or posterior compartment (35%). Quality of life scores improved from baseline to 5 years including: -68.5 and -74.3 for POPDI (adjusted mean difference [AMD] of 5.9; 95% CI ¼ -10.2, 21.9), -76.2, and -80.4 for UDI (AMD of 4.2; 95% CI ¼ -10.6, 19), and -42.4 and -44 for CRADI (AMD of 1.6; 95% CI ¼ -17.3, 20.5). Odds of granulation tissue (6 months to 5 years) were higher in the ULS group (OR ¼ 1.9; 95% CI ¼ 1e3.7) without group differences in suture exposure or mesh erosion/exposure. By year 5, the estimated probabilities of anatomic success for the PBMT group and the usual care group, respectively, were 0.54 and 0.54 (difference of 0.004; 95% CI ¼ -0.21, 0.22) with no treatment difference in improvement of POPDI scores -60 and -62 (AMD of 2.1; 95% CI ¼ -14, 18.1). CONCLUSION: Five years after vaginal surgery for Stage II-IV POP and SUI, women randomized to ULS and SSLF who consented to extended follow up have similar overall anatomic and subjective surgical cure rates, low rates of retreatment for POP, and significant improvement in quality of life. 
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